Retrospective study of thalidomide plus dexamethasone versus conventional chemotherapy in the relapsed multiple myeloma patient and the study of melphalan and prednisone versus melphalan, prednisone, and thalidomide. Hematol Meeting Rep [Internet]. 2009 Jun. 5 [cited 2025 Jun. 20];1(11). Available from: https://journals.pagepress.org/hmr/article/view/351